_id
6914880eccc777a4e85d975c
Ticker
ONCO
Name
Onconetix Inc
Exchange
NASDAQ
Address
201 East Fifth Street, Cincinnati, OH, United States, 45202
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.onconetix.com
Description
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Last Close
1.6
Volume
26031
Current Price
1.6
Change
0.05
Last Updated
2026-01-05T12:10:17.963Z
Image
-
Ipo Date
2022-02-18T00:00:00.000Z
Market Cap
2503575
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.897
Sentiment Sources
1
Rating
3
Target Price
9
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
303651
Cost Of Revenue
34757
Gross Profit
268894
Operating Expenses
2338136
Operating Income
-2069242
Interest Expense
300069
Pretax Income
-8783702
Net Income
-8783702
Eps
-6.249659010622077
Dividends Per Share
14753
Shares Outstanding
1555015
Income Tax Expense
-
EBITDA
-8480246
Operating Margin
-681.4540376945902
Total Other Income Expense Net
-6714460
Cash
836556
Short Term Investments
-
Receivables
2552
Inventories
151556
Total Current Assets
1302026
Property Plant Equipment
46543
Total Assets
19678868
Payables
1804163
Short Term Debt
166422
Long Term Debt
-
Total Liabilities
16303023
Equity
3374121
Bs_currency_symbol
USD
Depreciation
3387
Change In Working Capital
-1175466
Cash From Operations
-3177831
Capital Expenditures
1
Cash From Investing
-
Cash From Financing
4291150
Net Change In Cash
553041
Cf_currency_symbol
USD
PE
0.0013
PB
0.6664699932219383
ROE
-260.3256374030451
ROA
-44.63519954501448
FCF
-3177832
Fcf Percent
-10.465409302126455
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
6.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
3
Quality Investing Score
1
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
303651
Quarters > 0 > income Statement > cost Of Revenue
34757
Quarters > 0 > income Statement > gross Profit
268894
Quarters > 0 > income Statement > operating Expenses
2338136
Quarters > 0 > income Statement > operating Income
-2069242
Quarters > 0 > income Statement > interest Expense
300069
Quarters > 0 > income Statement > pretax Income
-8783702
Quarters > 0 > income Statement > net Income
-8783702
Quarters > 0 > income Statement > eps
-6.249659010622077
Quarters > 0 > income Statement > dividends Per Share
14753
Quarters > 0 > income Statement > shares Outstanding
1405469
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-8480246
Quarters > 0 > income Statement > operating Margin
-681.4540376945902
Quarters > 0 > income Statement > total Other Income Expense Net
-6714460
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
836556
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2552
Quarters > 0 > balance Sheet > inventories
151556
Quarters > 0 > balance Sheet > total Current Assets
1302026
Quarters > 0 > balance Sheet > property Plant Equipment
46543
Quarters > 0 > balance Sheet > total Assets
19678868
Quarters > 0 > balance Sheet > payables
1804163
Quarters > 0 > balance Sheet > short Term Debt
166422
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
16303023
Quarters > 0 > balance Sheet > equity
3374121
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-8783702
Quarters > 0 > cash Flow > depreciation
3387
Quarters > 0 > cash Flow > change In Working Capital
-1175466
Quarters > 0 > cash Flow > cash From Operations
-3177831
Quarters > 0 > cash Flow > capital Expenditures
1
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
4291150
Quarters > 0 > cash Flow > net Change In Cash
553041
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-6.249659010622077
Quarters > 0 > ratios > PB
0.6664699932219383
Quarters > 0 > ratios > ROE
-260.3256374030451
Quarters > 0 > ratios > ROA
-44.63519954501448
Quarters > 0 > ratios > FCF
-3177832
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-10.465409302126455
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
106494
Quarters > 1 > income Statement > cost Of Revenue
35991
Quarters > 1 > income Statement > gross Profit
70503
Quarters > 1 > income Statement > operating Expenses
2005921
Quarters > 1 > income Statement > operating Income
-1935418
Quarters > 1 > income Statement > interest Expense
223097
Quarters > 1 > income Statement > pretax Income
-2372442
Quarters > 1 > income Statement > net Income
-2372442
Quarters > 1 > income Statement > eps
-4.179424572974801
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
567648
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2145646
Quarters > 1 > income Statement > operating Margin
-1817.3962852367267
Quarters > 1 > income Statement > total Other Income Expense Net
-437024
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
283515
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
61169
Quarters > 1 > balance Sheet > inventories
153072
Quarters > 1 > balance Sheet > total Current Assets
930531
Quarters > 1 > balance Sheet > property Plant Equipment
65209
Quarters > 1 > balance Sheet > total Assets
19119036
Quarters > 1 > balance Sheet > payables
2581608
Quarters > 1 > balance Sheet > short Term Debt
8752971
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13209275
Quarters > 1 > balance Sheet > equity
5909761
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2372442
Quarters > 1 > cash Flow > depreciation
3699
Quarters > 1 > cash Flow > change In Working Capital
-68943
Quarters > 1 > cash Flow > cash From Operations
-1410296
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
744574
Quarters > 1 > cash Flow > net Change In Cash
-1293678
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-4.179424572974801
Quarters > 1 > ratios > PB
0.1536841845211676
Quarters > 1 > ratios > ROE
-40.14446607908509
Quarters > 1 > ratios > ROA
-12.408795087785807
Quarters > 1 > ratios > FCF
-1410296
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-13.242962044810037
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
101630
Quarters > 2 > income Statement > cost Of Revenue
55798
Quarters > 2 > income Statement > gross Profit
45832
Quarters > 2 > income Statement > operating Expenses
12616661
Quarters > 2 > income Statement > operating Income
-12570829
Quarters > 2 > income Statement > interest Expense
223592
Quarters > 2 > income Statement > pretax Income
-8545885
Quarters > 2 > income Statement > net Income
-8545885
Quarters > 2 > income Statement > eps
-39.964295401191556
Quarters > 2 > income Statement > dividends Per Share
394757
Quarters > 2 > income Statement > shares Outstanding
213838
Quarters > 2 > income Statement > income Tax Expense
-917997
Quarters > 2 > income Statement > EBITDA
-8317545
Quarters > 2 > income Statement > operating Margin
-12369.210862934173
Quarters > 2 > income Statement > total Other Income Expense Net
4024944
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1577193
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
67659
Quarters > 2 > balance Sheet > inventories
155660
Quarters > 2 > balance Sheet > total Current Assets
2420589
Quarters > 2 > balance Sheet > property Plant Equipment
145613
Quarters > 2 > balance Sheet > total Assets
18775711
Quarters > 2 > balance Sheet > payables
2581743
Quarters > 2 > balance Sheet > short Term Debt
9046160
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14258469
Quarters > 2 > balance Sheet > equity
4517242
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-8545885
Quarters > 2 > cash Flow > depreciation
4748
Quarters > 2 > cash Flow > change In Working Capital
-69511
Quarters > 2 > cash Flow > cash From Operations
-1999680
Quarters > 2 > cash Flow > capital Expenditures
3874
Quarters > 2 > cash Flow > cash From Investing
-3874
Quarters > 2 > cash Flow > cash From Financing
2870254
Quarters > 2 > cash Flow > net Change In Cash
930693
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-39.964295401191556
Quarters > 2 > ratios > PB
0.07574108272259933
Quarters > 2 > ratios > ROE
-189.18368774575282
Quarters > 2 > ratios > ROA
-45.51563986045588
Quarters > 2 > ratios > FCF
-2003554
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-19.714198563416314
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
711976
Quarters > 3 > income Statement > cost Of Revenue
52008
Quarters > 3 > income Statement > gross Profit
659968
Quarters > 3 > income Statement > operating Expenses
2684058
Quarters > 3 > income Statement > operating Income
-1972082
Quarters > 3 > income Statement > interest Expense
248349
Quarters > 3 > income Statement > pretax Income
-30356339
Quarters > 3 > income Statement > net Income
-29438342
Quarters > 3 > income Statement > eps
-212.87705368506306
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
138288
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-276.9871456341225
Quarters > 3 > income Statement > total Other Income Expense Net
-28135926
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
646500
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
25717
Quarters > 3 > balance Sheet > inventories
64079
Quarters > 3 > balance Sheet > total Current Assets
950267
Quarters > 3 > balance Sheet > property Plant Equipment
182323
Quarters > 3 > balance Sheet > total Assets
28181563
Quarters > 3 > balance Sheet > payables
3787564
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
18571008
Quarters > 3 > balance Sheet > equity
9610555
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-29438342
Quarters > 3 > cash Flow > depreciation
119299
Quarters > 3 > cash Flow > change In Working Capital
774699
Quarters > 3 > cash Flow > cash From Operations
-917647
Quarters > 3 > cash Flow > capital Expenditures
3874
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1302800
Quarters > 3 > cash Flow > net Change In Cash
305005
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-212.87705368506306
Quarters > 3 > ratios > PB
0.02302268703524406
Quarters > 3 > ratios > ROE
-306.3126114985035
Quarters > 3 > ratios > ROA
-104.45957876786322
Quarters > 3 > ratios > FCF
-921521
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.2943146960009888
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2524116
Annuals > 0 > income Statement > cost Of Revenue
1469018
Annuals > 0 > income Statement > gross Profit
1055098
Annuals > 0 > income Statement > operating Expenses
57543853
Annuals > 0 > income Statement > operating Income
-56488755
Annuals > 0 > income Statement > interest Expense
1407678
Annuals > 0 > income Statement > pretax Income
-59736203
Annuals > 0 > income Statement > net Income
-58691023
Annuals > 0 > income Statement > eps
-1817.0595356037152
Annuals > 0 > income Statement > dividends Per Share
206404
Annuals > 0 > income Statement > shares Outstanding
32300
Annuals > 0 > income Statement > income Tax Expense
-1045180
Annuals > 0 > income Statement > EBITDA
-57597180
Annuals > 0 > income Statement > operating Margin
-2237.961924095406
Annuals > 0 > income Statement > total Other Income Expense Net
-3247448
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
646500
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
96308
Annuals > 0 > balance Sheet > inventories
64079
Annuals > 0 > balance Sheet > total Current Assets
950267
Annuals > 0 > balance Sheet > property Plant Equipment
182323
Annuals > 0 > balance Sheet > total Assets
28181563
Annuals > 0 > balance Sheet > payables
3787564
Annuals > 0 > balance Sheet > short Term Debt
9447488
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
18571008
Annuals > 0 > balance Sheet > equity
9610555
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-58691023
Annuals > 0 > cash Flow > depreciation
731345
Annuals > 0 > cash Flow > change In Working Capital
-1541362
Annuals > 0 > cash Flow > cash From Operations
-10495816
Annuals > 0 > cash Flow > capital Expenditures
28471
Annuals > 0 > cash Flow > cash From Investing
-28471
Annuals > 0 > cash Flow > cash From Financing
6743110
Annuals > 0 > cash Flow > net Change In Cash
-3907835
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1817.0595356037152
Annuals > 0 > ratios > PB
0.0054110298520741
Annuals > 0 > ratios > ROE
-610.6933782700374
Annuals > 0 > ratios > ROA
-208.2603544735968
Annuals > 0 > ratios > FCF
-10524287
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.169494191233683
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
58465
Annuals > 1 > income Statement > cost Of Revenue
1185630
Annuals > 1 > income Statement > gross Profit
-1127165
Annuals > 1 > income Statement > operating Expenses
34907430
Annuals > 1 > income Statement > operating Income
-36034595
Annuals > 1 > income Statement > interest Expense
671625
Annuals > 1 > income Statement > pretax Income
-37422287
Annuals > 1 > income Statement > net Income
-37409694
Annuals > 1 > income Statement > eps
-7434.358903020668
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5032
Annuals > 1 > income Statement > income Tax Expense
-12593
Annuals > 1 > income Statement > EBITDA
-36706725
Annuals > 1 > income Statement > operating Margin
-61634.47361669375
Annuals > 1 > income Statement > total Other Income Expense Net
-1387692
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4554335
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
149731
Annuals > 1 > balance Sheet > inventories
364052
Annuals > 1 > balance Sheet > total Current Assets
5838271
Annuals > 1 > balance Sheet > property Plant Equipment
209196
Annuals > 1 > balance Sheet > total Assets
87518032
Annuals > 1 > balance Sheet > payables
5295114
Annuals > 1 > balance Sheet > short Term Debt
9692625
Annuals > 1 > balance Sheet > long Term Debt
118857
Annuals > 1 > balance Sheet > total Liabilities
86113556
Annuals > 1 > balance Sheet > equity
-5602028
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-37409694
Annuals > 1 > cash Flow > depreciation
43937
Annuals > 1 > cash Flow > change In Working Capital
1622975
Annuals > 1 > cash Flow > cash From Operations
-13581018
Annuals > 1 > cash Flow > capital Expenditures
55044
Annuals > 1 > cash Flow > cash From Investing
-8649035
Annuals > 1 > cash Flow > cash From Financing
1035060
Annuals > 1 > cash Flow > net Change In Cash
-21198324
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-7434.358903020668
Annuals > 1 > ratios > PB
-0.0014461762775909012
Annuals > 1 > ratios > ROE
667.7884151953543
Annuals > 1 > ratios > ROA
-42.74512708421049
Annuals > 1 > ratios > FCF
-13636062
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-233.2346190028222
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
6752
Annuals > 2 > income Statement > gross Profit
-6752
Annuals > 2 > income Statement > operating Expenses
13481240
Annuals > 2 > income Statement > operating Income
-13481240
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-13419830
Annuals > 2 > income Statement > net Income
-13419830
Annuals > 2 > income Statement > eps
-3718.4344693821004
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3609
Annuals > 2 > income Statement > income Tax Expense
-61410
Annuals > 2 > income Statement > EBITDA
-13413078
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
61410
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
25752659
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
35850
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
26257741
Annuals > 2 > balance Sheet > property Plant Equipment
14089
Annuals > 2 > balance Sheet > total Assets
26310447
Annuals > 2 > balance Sheet > payables
1499296
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3922445
Annuals > 2 > balance Sheet > equity
22388002
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-13419830
Annuals > 2 > cash Flow > depreciation
6752
Annuals > 2 > cash Flow > change In Working Capital
2560464
Annuals > 2 > cash Flow > cash From Operations
-8675534
Annuals > 2 > cash Flow > capital Expenditures
9339
Annuals > 2 > cash Flow > cash From Investing
-32665
Annuals > 2 > cash Flow > cash From Financing
32532384
Annuals > 2 > cash Flow > net Change In Cash
23824185
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3718.4344693821004
Annuals > 2 > ratios > PB
0.0002595358889104977
Annuals > 2 > ratios > ROE
-59.94206182400734
Annuals > 2 > ratios > ROA
-51.00570887298114
Annuals > 2 > ratios > FCF
-8684873
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4890
Annuals > 3 > income Statement > gross Profit
-4890
Annuals > 3 > income Statement > operating Expenses
3417334
Annuals > 3 > income Statement > operating Income
-3417334
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-3417334
Annuals > 3 > income Statement > net Income
-3417334
Annuals > 3 > income Statement > eps
-1051.8110187750076
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3249
Annuals > 3 > income Statement > income Tax Expense
-4
Annuals > 3 > income Statement > EBITDA
-3412444
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-4
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1928474
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
152524
Annuals > 3 > balance Sheet > inventories
757646
Annuals > 3 > balance Sheet > total Current Assets
3073195
Annuals > 3 > balance Sheet > property Plant Equipment
11502
Annuals > 3 > balance Sheet > total Assets
3084697
Annuals > 3 > balance Sheet > payables
582605
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1638120
Annuals > 3 > balance Sheet > equity
1446577
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3417334
Annuals > 3 > cash Flow > depreciation
4890
Annuals > 3 > cash Flow > change In Working Capital
1214627
Annuals > 3 > cash Flow > cash From Operations
-2044235
Annuals > 3 > cash Flow > capital Expenditures
1924
Annuals > 3 > cash Flow > cash From Investing
-1924
Annuals > 3 > cash Flow > cash From Financing
-334188
Annuals > 3 > cash Flow > net Change In Cash
-2380347
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1051.8110187750076
Annuals > 3 > ratios > PB
0.0036160467088858735
Annuals > 3 > ratios > ROE
-236.2358865100164
Annuals > 3 > ratios > ROA
-110.78345782422065
Annuals > 3 > ratios > FCF
-2046159
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
23
Valuation > metrics > PE
0.0013
Valuation > metrics > PB
0.6664699932219383
Valuation > final Score
90
Valuation > verdict
66.7% Undervalued
Profitability > metrics > ROE
-260.3256374030451
Profitability > metrics > ROA
-674.6180183805853
Profitability > metrics > Net Margin
-28.92696549657337
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.831783744566363
Risk > metrics > Interest Coverage
-6.895887279259104
Risk > final Score
-22
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.6607306967220394
Liquidity > metrics > Quick Ratio
0.583821555527927
Liquidity > final Score
39
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-17
Prev Risks > 1
-219
Prev Risks > 2
-2
Prev Liquidities > 0
13
Prev Liquidities > 1
20
Prev Liquidities > 2
22
Updated At
2026-01-20T22:20:44.628Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-28
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-6.25
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-6.25
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-4.18
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-4.18
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-45.44
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-06
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.93
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-249.0759
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2191.4855
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-20
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.502
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
-0.292
Earnings History > 6 > surprise Percent
-139.0476
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-3404.0048
Earnings History > 7 > eps Estimate
-0.21
Earnings History > 7 > eps Difference
-3403.7948
Earnings History > 7 > surprise Percent
-1620854.6667
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.19
Earnings History > 8 > eps Estimate
-0.19
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-612
Earnings History > 9 > eps Estimate
-0.18
Earnings History > 9 > eps Difference
-611.82
Earnings History > 9 > surprise Percent
-339900
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.2
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
10
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-09
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-680
Earnings History > 11 > eps Estimate
-0.2
Earnings History > 11 > eps Difference
-679.8
Earnings History > 11 > surprise Percent
-339900
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-918
Earnings History > 12 > eps Estimate
-0.27
Earnings History > 12 > eps Difference
-917.73
Earnings History > 12 > surprise Percent
-339900
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.36
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.34
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-23
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.12
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.12
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-05
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.05
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.05
Earnings History > 16 > surprise Percent
-
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOnco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services - Stock Titan
1/21/2026
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services Stock Titan
Read more →Oncopeptides Lifts 2025 Sales but Delays Cash-Flow Break-Even to 2027 TipRanks
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$9
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Onconetix Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-6.25
EPS Estimate
0
EPS Difference
-6.25
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.